Sidhya Choudhary: First Author? Third Author? Or… No Credit At All?
Sidhya Choudhary, Assistant Professor at Dr. Sampurnanand Medical College, posted on LinkedIn:
”First author? Third author? Or… no credit at all?
When I submitted my first paper, I honestly believed:
“The corresponding author should count, right?”
Back then, just seeing my name in print felt like an achievement.
Until I read the fine print.
Under NMC guidelines, it doesn’t.
Only 1st, 2nd, or 3rd author get credit for promotions.
Only original research, systematic reviews, meta-analyses, or case series count.
Only journals indexed in PubMed, Scopus, Embase, Medline, Science Citation Index, or DOAJ qualify.
So if you’re the 4th or 5th author – even after months of data collection, late nights, and endless edits – your work may be invisible.
And that stings. Because research is never a one-person job.
Patients, data, writing—the load always falls on many shoulders, not just three.
What can help?
– Talk about authorship early.
– Rotate leadership so juniors get 1st/2nd slots.
– Check indexing before you celebrate acceptance.
– Senior mentors guiding journal choice makes a huge difference.
The rules may not change overnight.
But how do we share credit? That can start with us.
Do you think current authorship rules truly reflect contribution – or is it time we rethink how credit is given?”

Keep up with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
